The abstract is read at the publisher; the summary is JClub's.
PTK7 in triple-negative breast cancer scaffolds DNA-PKcs in the nucleus, boosting NHEJ repair and dampening STING-IFN signaling linked to immune evasion.
- Why it matters: The intracellular role of PTK7 in coordinating DNA damage response and tumor immune control in TNBC is unclear, limiting biomarker and therapeutic opportunities.
- What they did: PTK7 was shown to translocate to the nucleus and associate with DNA-PKcs, enhancing kinase activation and NHEJ; PTK7 loss increased double-strand breaks and activated the STING-IFN axis.
- The result: PTK7 deficiency sensitized TNBC tumors to anti-PD-1 therapy in vivo, and high PTK7 expression correlated with suppressed immune signatures and poor immunotherapy response in TNBC patients.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.